Investor Intelligence Business Intelligence (IIBI)
Recent Achievements Annovis Bio continues to advance its mission of developing transformative therapies for neurodegenerative disorders. The company recently announced statistically significant data from its Phase II/III Alzheimer’s study, demonstrating the potential of its lead drug candidate, buntanetap, to improve cognition in patients with early Alzheimer’s Disease (AD). Additionally, the company has released promising data … Continue reading “Annovis Bio Inc. (NYSE: ANVS)”
Greenwave Technology Solutions Inc., through its wholly owned subsidiary Empire Services Inc., operates a network of 13 metal recycling facilities located across Virginia, North Carolina, and Ohio. These facilities specialize in the collection, classification, and processing of raw scrap metal, both ferrous and nonferrous.
WiSA Technologies Inc. is a pioneering leader in immersive, wireless sound technology, providing cutting-edge audio solutions for intelligent devices and next-generation home entertainment systems. The company collaborates with top consumer electronics (CE) brands and manufacturers, including industry giants like Harman International (a division of Samsung), LG, Hisense, TCL, Bang & Olufsen, and Platin Audio.
Telomir Pharmaceuticals Inc. is a pre-clinical-stage pharmaceutical company focused on developing and commercializing Telomir-1, a groundbreaking small molecule designed to lengthen DNA’s protective telomere caps. Telomeres, the end caps of chromosomes, play a crucial role in protecting DNA from degradation, but they naturally shorten as humans and animals age, contributing to the onset of degenerative and age-related diseases.
NanoViricides Inc. is a clinical stage global leader in the development of nanomedicine drugs against viruses. Going beyond what antibodies and immunotherapeutics do, the company’s unique nanoviricide® platform technology is designed to specifically target and dismantle enveloped virus particles, offering a novel approach to treating a wide range of viral infections.
Gaxos.ai Inc. is revolutionizing the human-AI relationship, pushing the boundaries of artificial intelligence to offer solutions that resonate on a human level. The company's mission extends beyond application development; it aims to integrate AI into various aspects of human existence, transforming how people interact with technology.
Tonix Pharmaceuticals Holding Corp. is a fully-integrated biopharmaceutical company dedicated to developing, licensing, and commercializing innovative therapeutics aimed at treating and preventing human diseases and alleviating suffering.
Silo Pharma Inc. is a cutting-edge biopharmaceutical company focused on developing novel therapeutics to address underserved medical conditions, particularly in the fields of stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases.
Oragenics Inc. is a development-stage biotechnology company pioneering innovative solutions in pharmaceutical medications, with a focus on nasal delivery systems.
Whether you prefer a traditional online meeting (IBN Studios) or an immersive VR meeting in the metaverse (IBN VR), IBN has you covered.
8033 Sunset Blvd. Suite IIBI-1037
Los Angeles, CA 90046
(310) 299-1717
Copyright © . IIBI.ai / 8033 Sunset Blvd. Suite iibi-1037, Los Angeles, CA 90046 (310) 299-1717 / Disclaimers
Forms are protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.